UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Dynamic FDG-PET/CT in the Initial Staging of Primary Breast Cancer: Clinicopathological Correlations

Pathology oncology research, 2020-04, Vol.26 (2), p.997-1006

2020

Volltextzugriff (PDF)

Ki-67 as a controversial predictive and prognostic marker in breast cancer patients treated with neoadjuvant chemotherapy

Diagnostic pathology, 2017-02, Vol.12 (1), p.20-20, Article 20

2017

Volltextzugriff (PDF)

Prognostic and Clinicopathological Correlations of Cell Cycle Marker Expressions before and after the Primary Systemic Therapy of Breast Cancer

Pathology oncology research, 2020-07, Vol.26 (3), p.1499-1510

2020

Volltextzugriff (PDF)

Predictive and prognostic value of FDG-PET/CT imaging and different response evaluation criteria after primary systemic therapy of breast cancer

Breast cancer (Tokyo, Japan), 2017, Vol.24 (1), p.137-146

2017

Volltextzugriff (PDF)

Complexity of Response Evaluation During Primary Systemic Therapy of Breast Cancer: Scoring Systems and Beyond-Preliminary Results

Anticancer research, 2015-09, Vol.35 (9), p.5063-5072

2015

Volltextzugriff (PDF)

Influence of mutagenic versus non-mutagenic pre-operative chemotherapy on the immune infiltration of residual breast cancer

Acta oncologica, 2019-11, Vol.58 (11), p.1603-1611

2019

Volltextzugriff (PDF)

AXL-associated tumor inflammation as a poor prognostic signature in chemotherapy-treated triple-negative breast cancer patients

NPJ breast cancer, 2016-11, Vol.2 (1), p.16033-16033, Article 16033

2016

Volltextzugriff (PDF)

Primary systemic therapy for breast cancer: Does the patient's involvement in decision-making create a new future?

Patient education and counseling, 2015-06, Vol.98 (6), p.695-703

2015

Volltextzugriff (PDF)

Investigating the Prognostic Relevance of Tumor Immune Microenvironment and Immune Gene Assembly in Breast Carcinoma Subtypes

Cancers, 2022-04, Vol.14 (8), p.1942

2022

Volltextzugriff (PDF)

Expression of cell cycle markers is predictive of the response to primary systemic therapy of locally advanced breast cancer

Virchows Archiv : an international journal of pathology, 2016-06, Vol.468 (6), p.675-686

2016

Volltextzugriff (PDF)

Morphological and pathological response in primary systemic therapy of patients with breast cancer and the prediction of disease free survival: a single center observational study

Croatian medical journal, 2016-04, Vol.57 (2), p.131-139

2016

Volltextzugriff (PDF)

Response evaluation after primary systemic therapy of Her2 positive breast cancer – an observational cross-sectional study

Croatian medical journal, 2015-04, Vol.56 (2), p.128-138

2015

Volltextzugriff (PDF)

FDG-PET-CT in the early response evaluation for primary systemic therapy of breast cancer

Central European journal of medicine, 2014-04, Vol.9 (2), p.306-312

2014

Volltextzugriff (PDF)

Response Evaluation with Dynamic FDG PET/CT during the Primary Systemic Therapy of Breast Cancer - A Case Report

Annals of Clinical Oncology, 2021-08, p.1-4

2021

Volltextzugriff (PDF)

Defining the design space for freeze-dried orodispersible tablets with meloxicam

Drug development and industrial pharmacy, 2016-12, Vol.42 (12), p.1977-1989

2016

Volltextzugriff (PDF)

Comparison of different motion correction techniques for dynamic FDG-PET/CT studies in breast cancer patients

The quarterly journal of nuclear medicine and molecular imaging, 2020-12, Vol.64 (4)

2020

Volltextzugriff (PDF)

Complexity of the response evaluation during primary systemic therapy of breast cancer

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.e12010-e12010

2014

Volltextzugriff (PDF)

PET-CT Imaging in Breast Cancer Patients: New Tracers, Future Directions

Journal of molecular imaging & dynamics, 2013, Vol.2 (2)

Magdolna Dank Med. Habil, Timea Tokes

2013

Volltextzugriff (PDF)

Monoclonal antibody therapy in breast cancer

Magyar onkologia, 2013-09, Vol.57 (3), p.157

2013

Volltextzugriff (PDF)

Correlation of the value of 18F-FDG uptake, described by SUVmax, SUVavg, metabolic tumour volume and total lesion glycolysis, to clinicopathological prognostic factors and biological subtypes in breast cancer

Nuclear medicine communications, 2015-01, Vol.36 (1), p.28-37

2015

Volltextzugriff (PDF)

The role of FDG-PET-CT in the evaluation of primary systemic therapy in breast cancer: links between metabolic and pathological remission

Orvosi hetilap, 2012-12, Vol.153 (49), p.1958-1964

2012

Volltextzugriff (PDF)

Response evaluation after primary systemic therapy of Her2 positive breast cancer – an observational crosssectional study

Croatian medical journal, 2015-04, Vol.56 (2), p.128

2015

Volltextzugriff (PDF)

The Prediction Analysis of Microarray 50 (PAM50) Gene Expression Classifier Utilized in Indeterminate-Risk Breast Cancer Patients in Hungary: A Consecutive 5-Year Experience

Genes, 2023-08, Vol.14 (9), p.1708

2023

Volltextzugriff (PDF)

Nitrones are able to release nitric oxide in aqueous environment under hydroxyl free radical attack

Nitric oxide, 2011-10, Vol.25 (3), p.309-315

2011

Volltextzugriff (PDF)

1 – 25 von 26

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(23)
Mit Volltextzugriff
(21)

Publikationsform

Artikel
(26)

Sprache

Englisch
(24)
Ungarisch
(2)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(18)
Science & Technology
(18)
Female
(14)
Humans
(14)
Breast Cancer
(13)
Adult
(12)
Middle Aged
(11)
Aged
(10)
Breast Neoplasms - Drug Therapy
(9)
Breast Neoplasms - Pathology
(8)
Oncology
(8)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(6)
Primary Systemic Therapy
(6)
Breast Neoplasms - Diagnostic Imaging
(5)
Breast Neoplasms - Metabolism
(5)
Care And Treatment
(5)
Tumors
(5)
Antineoplastic Agents - Therapeutic Use
(4)
Biomedicine
(4)
Cancer Research
(4)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Dynamic FDG-PET/CT in the Initial Staging of Primary Breast Cancer: Clinicopathological Correlations

Ki-67 as a controversial predictive and prognostic marker in breast cancer patients treated with neoadjuvant chemotherapy

Prognostic and Clinicopathological Correlations of Cell Cycle Marker Expressions before and after the Primary Systemic Therapy of Breast Cancer

Predictive and prognostic value of FDG-PET/CT imaging and different response evaluation criteria after primary systemic therapy of breast cancer

Complexity of Response Evaluation During Primary Systemic Therapy of Breast Cancer: Scoring Systems and Beyond-Preliminary Results

Influence of mutagenic versus non-mutagenic pre-operative chemotherapy on the immune infiltration of residual breast cancer

AXL-associated tumor inflammation as a poor prognostic signature in chemotherapy-treated triple-negative breast cancer patients

Primary systemic therapy for breast cancer: Does the patient's involvement in decision-making create a new future?

Investigating the Prognostic Relevance of Tumor Immune Microenvironment and Immune Gene Assembly in Breast Carcinoma Subtypes

Expression of cell cycle markers is predictive of the response to primary systemic therapy of locally advanced breast cancer

Morphological and pathological response in primary systemic therapy of patients with breast cancer and the prediction of disease free survival: a single center observational study

Response evaluation after primary systemic therapy of Her2 positive breast cancer – an observational cross-sectional study

FDG-PET-CT in the early response evaluation for primary systemic therapy of breast cancer

Response Evaluation with Dynamic FDG PET/CT during the Primary Systemic Therapy of Breast Cancer - A Case Report

Defining the design space for freeze-dried orodispersible tablets with meloxicam

Comparison of different motion correction techniques for dynamic FDG-PET/CT studies in breast cancer patients

Complexity of the response evaluation during primary systemic therapy of breast cancer

PET-CT Imaging in Breast Cancer Patients: New Tracers, Future Directions

Monoclonal antibody therapy in breast cancer

Correlation of the value of 18F-FDG uptake, described by SUVmax, SUVavg, metabolic tumour volume and total lesion glycolysis, to clinicopathological prognostic factors and biological subtypes in breast cancer

The role of FDG-PET-CT in the evaluation of primary systemic therapy in breast cancer: links between metabolic and pathological remission

Response evaluation after primary systemic therapy of Her2 positive breast cancer – an observational crosssectional study

The Prediction Analysis of Microarray 50 (PAM50) Gene Expression Classifier Utilized in Indeterminate-Risk Breast Cancer Patients in Hungary: A Consecutive 5-Year Experience

Haemorheological and haemostatic alterations in coeliac disease and inflammatory bowel disease in comparison with non-coeliac, non-IBD subjects (HERMES): a case–control study protocol

Nitrones are able to release nitric oxide in aqueous environment under hydroxyl free radical attack

Suchergebnisse filtern